Suppr超能文献

在幼龄动物体内,突触效能的长时程抑制需要GluR2亚基的酪氨酸磷酸化。

Tyrosine phosphorylation of the GluR2 subunit is required for long-term depression of synaptic efficacy in young animals in vivo.

作者信息

Fox Christopher J, Russell Kyle, Titterness Andrea K, Wang Yu Tian, Christie Brian R

机构信息

Neuroscience Program, The University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

Hippocampus. 2007;17(8):600-5. doi: 10.1002/hipo.20302.

Abstract

The study of the intracellular mechanics that underlay changes in synaptic efficacy is a rapidly evolving field of research. It is currently believed that NMDA receptors play a significant role in the induction of synaptic plasticity, whereas AMPA receptors play a significant role in its expression. For AMPA receptors, it has been shown that tyrosine phosphorylation of the GluR2 carboxyl termini is required for the expression of long-term depression of synaptic efficacy (LTD) in vitro (Ahmadian et al. (2004) EMBO J 23:1040-1050). In the present study, we sought to determine whether similar mechanisms are involved in vivo, where different stimulation parameters are required for the induction of LTD. We initially used a paired-burst (PB) paradigm that reliably induces LTD in vivo. In these animals we were able to prevent the induction and expression of PB-LTD by administering a peptide (GluR-3Y) that acted as a competitive inhibitor of tyrosine phosphorylation. In a separate set of animals, we exposed animals to brief periods of stress (S) before using low-frequency stimuli to induce LTD (S-LTD). Again, GluR2-3Y blocked both the induction and expression of S-LTD. In contrast, an inert version of the peptide, with alanine replacing the three tyrosine residues, did not inhibit LTD induction. In addition, we demonstrated that GluR2-3Y did not affect the induction of long-term potentiation in vivo. These findings support the hypothesis that tyrosine phosphorylation and AMPA receptor endocytosis are necessary steps for the induction and maintenance of two forms of LTD in the CA1 region.

摘要

对作为突触效能变化基础的细胞内机制的研究是一个快速发展的研究领域。目前认为,N-甲基-D-天冬氨酸(NMDA)受体在突触可塑性的诱导中起重要作用,而α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)受体在其表达中起重要作用。对于AMPA受体,已经表明,体外突触效能长时程抑制(LTD)的表达需要GluR2羧基末端的酪氨酸磷酸化(Ahmadian等人,(2004年)《欧洲分子生物学组织杂志》23:1040 - 1050)。在本研究中,我们试图确定体内是否涉及类似机制,在体内诱导LTD需要不同的刺激参数。我们最初使用了一种配对脉冲(PB)范式,该范式能可靠地在体内诱导LTD。在这些动物中,我们能够通过给予一种作为酪氨酸磷酸化竞争性抑制剂的肽(GluR - 3Y)来阻止PB - LTD的诱导和表达。在另一组动物中,我们在使用低频刺激诱导LTD(S - LTD)之前,让动物暴露于短暂的应激(S)中。同样,GluR2 - 3Y阻断了S - LTD的诱导和表达。相比之下,用丙氨酸取代三个酪氨酸残基的该肽的惰性形式并不抑制LTD的诱导。此外,我们证明GluR2 - 3Y不影响体内长时程增强的诱导。这些发现支持了以下假设:酪氨酸磷酸化和AMPA受体内吞作用是CA1区两种形式LTD诱导和维持的必要步骤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验